Location History:
- Jerusalem, IL (1997)
- Mevasseret-Zion, IL (1999)
Company Filing History:
1 out of 31 
1 out of 184 Years Active: 1997-1999
Title: David Gross: Innovator in Diabetes Treatment
Introduction
David Gross is a notable inventor based in Jerusalem, Israel. He has made significant contributions to the field of diabetes treatment, holding 2 patents that showcase his innovative approach to managing this chronic condition. His work has the potential to impact the lives of many individuals suffering from diabetes.
Latest Patents
David Gross's latest patents include a composition for the treatment of diabetes, which features an immunoregulator, preferably Linomide, and a beta cell proliferative agent, preferably reg protein. This composition has demonstrated effectiveness in both inhibiting the progression of diabetes and reversing the course of the disease in the NOD mouse model. Additionally, he has developed a method involving the use of quinoline-3-carboxamide compounds for the treatment of diabetes.
Career Highlights
Throughout his career, David Gross has worked with various organizations, including Hadasit Medical Research Services and Development Company and Pharmacia Ab. His experience in these companies has allowed him to refine his research and contribute to advancements in medical treatments.
Collaborations
David has collaborated with notable individuals in his field, including Lola Weiss and Shimon Slavin. These partnerships have further enriched his research and development efforts.
Conclusion
David Gross is a pioneering inventor whose work in diabetes treatment is paving the way for innovative solutions in healthcare. His contributions are vital in the ongoing battle against diabetes, and his patents reflect his commitment to improving patient outcomes.